COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy

Vasa. 2020 Jun;49(4):333-337. doi: 10.1024/0301-1526/a000880. Epub 2020 May 28.

Abstract

COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse.

Keywords: COVID-19; anticoagulants; mechanical thrombolysis; pulmonary embolism; thrombectomy.

Publication types

  • Case Reports

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / therapy
  • Fibrinolytic Agents
  • Humans
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / therapy
  • Pulmonary Embolism / surgery*
  • Pulmonary Embolism / virology*
  • SARS-CoV-2
  • Thrombectomy*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents